This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

InterMune Inc
ITMN : NASDAQ : Health Care
$53.21 | %
Today's Range: 0.00 - 0.00
Avg. Daily Volume: 2,078,600
08/21/14 - 4:00 PM ET

PEER GROUP: Biotechnology



Ticker Company Name Recent
Price($)
Market
Cap($M)
Price/
Earnings
Net Sales
TTM($M)
Net Income
TTM($M)
ITMN INTERMUNE INC 51.54 5564.72 n/m 111.42 173.85
BMRN BIOMARIN PHARMACEUTICAL INC 67.67 9955.41 n/m 627.09 19.49
PCYC PHARMACYCLICS INC 124.17 9346.28 111.86 435.04 606.45
INCY INCYTE CORP 51.08 8602.49 n/m 371.57 7.05
MDVN MEDIVATION INC 84.22 6467.17 311.93 391.92 79.56
ICPT INTERCEPT PHARMA INC 296.36 6288.17 n/m 1.66 -4.43
SGEN SEATTLE GENETICS INC 42.57 5255.18 n/m 274.96 12.39
ALNY ALNYLAM PHARMACEUTICALS INC 66.97 5113.49 n/m 35.41 -32.67
CBST CUBIST PHARMACEUTICALS INC 63.59 4815.86 3179.50 1121.37 15.27
ISIS ISIS PHARMACEUTICALS INC 36.58 4306.98 n/m 151.07 33.77
UTHR UNITED THERAPEUTICS CORP 89.76 4242.87 17.60 1203.45 18.91
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

ITMN Ind Avg S&P 500
n/m 79.45 19.39
 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades

Brokerage Partners


Top Rated Stocks Top Rated Funds Top Rated ETFs